-+ 0.00%
-+ 0.00%
-+ 0.00%

ATEA PHARMACEUTICALS INITIATES FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL OF AT-587 FOR THE TREATMENT OF HEPATITIS E VIRUS

Reuters·07/14/2026 11:00:02

Please log in to view news